The DOI matches its Crossref record.
Evaluation and Treatment of Jaundice in the Term Newborn: A Kinder, Gentler Approach
Abstract
Standard recommendations for evaluating and treating jaundice in term babies include following all babies closely for jaundice, obtaining several laboratory tests in those with early jaundice or bilirubin levels more than 12 to 13 mg/dL (205 to 222 µmol/L), using phototherapy to try to keep bilirubin levels below 20 mg/dL (342 µmol/L), and doing exchange transfusions if phototherapy fails, regardless of the cause of the jaundice. These recommendations are likely to lead to unnecessary testing and treatment of many jaundiced term infants. Because most jaundiced infants have no underlying illness, and the generally recommended laboratory tests lack sensitivity and specificity, they are seldom useful. In most babies, the only blood tests needed to evaluate jaundice are the blood type and group (of baby and mother) and a direct Coombs' test. A determination of direct bilirubin level should be added if jaundice is prolonged (>2 to 4 weeks) or the baby has other signs of illness. Bilirubin toxicity is rare in term babies without hemolysis. In this low-risk group, the risks and cost of identifying and treating high bilirubin levels may exceed the benefits. Such infants need not be closely followed for jaundice. If significant jaundice is nonetheless found, treatment should be deferred to relatively high levels of serum bilirubin, with a goal of keeping bilirubin levels below 400 to 500 µmol/L (23.4 to 29.2 mg/dL). Babies with hemolytic disease should be followed more closely, and their bilirubin levels kept below 300 to 400 µmol/L (17.5 to 23.4 mg/dL). These recommendations should be reevaluated as new data become available. In the meantime, currently available data justify an approach to the jaundiced term infant that is less aggressive than previously recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Glucose-6-phosphate dehydrogenase deficiency
Cappellini, M., & Fiorelli, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60073-2 · Cited by 1,590
Pharmacological and Clinical Aspects of Heme Oxygenase
Abraham, N. G., & Kappas, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07104 · Cited by 1,115
“There is much debate on what constitutes a toxic level of bilirubin and on the methodology of treatment (Newman and Maisels, 1992; Dodd, 1993).”
Bhutani, V. K., Johnson, L., & Sivieri, E. M. (1999) · Pediatrics · doi:10.1542/peds.103.1.6 · Cited by 894
Doré, S., Takahashi, M., Ferris, C. D., Hester, L. D., Guastella, D., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2445 · Cited by 699
Dennery, P. A., Seidman, D. S., & Stevenson, D. K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440807 · Cited by 598
Neuzil, J., & Stocker, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89449-8 · Cited by 508
Bhutani, V. K., Gourley, G. R., Adler, S., Kreamer, B., Dalin, C., & Johnson, L. H. (2000) · Pediatrics · doi:10.1542/peds.106.2.e17 · Cited by 417
Battery-free, stretchable optoelectronic systems for wireless optical characterization of the skin
Kim, J., Salvatore, G. A., Araki, H., Chiarelli, A. M., Xie, Z., Banks, A., Sheng, X., Liu, Y., Lee, J. W., Jang, K.-I., et al. (2016) · Science Advances · doi:10.1126/sciadv.1600418 · Cited by 403
System-based approach to management of neonatal jaundice and prevention of kernicterus
Johnson, L. H., Bhutani, V. K., & Brown, A. K. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.123098 · Cited by 344
Glucose-6-phosphate dehydrogenase deficiency
Mehta, A., Mason, P. J., & Vulliamy, T. J. (2000) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.1999.0055 · Cited by 321
Rehospitalisation after birth hospitalisation: patterns among infants of all gestations
Escobar, G. J. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2003.039974 · Cited by 321
Metadata
- Authors
- Newman, T. B., & Maisels, M. J.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1992-05-01
- Volume
- 89
- Issue
- 5
- Pages
- 809-818
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1927123280
- Cited by
- 290
- References
- 0
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.